Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Merendino Procedure for Benign or Early Malignant Lesions of the Distal Esophagus/Gastroesophageal Junction is Feasible, Safe and Provides Good QoL

NCT02855333 is registered in ClinicalTrials.gov with Kantonsspital Liestal as lead sponsor.

NCT NCT02855333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02855333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Merendino Procedure for Benign or Early Malignant Lesions of the Distal Esophagus/Gastroesophageal Junction is Feasible, Safe and Provides Good QoL
Lead sponsor
Kantonsspital Liestal
Phase
Observational
Overall status
Completed
Start date
May 31, 2014
Completion date
May 31, 2016
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign or early malignant lesion of the distal esophagus or gastro-esophageal junction requiring surgical resection